Post Marketing Survey of Vesicare in Japan

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

NCT00658684 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

NCT00454896 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Specified Drug Use-results Survey of Betanis Tablets

NCT01901120 ·Status: COMPLETED

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

NCT02501928 ·Status: COMPLETED ·Phase: PHASE3

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

NCT01819168 ·Status: COMPLETED

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)

NCT00431041 ·Status: COMPLETED ·Phase: PHASE4

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01604928 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 ·Status: COMPLETED ·Phase: PHASE3

Study of ONO-8577 in Patients With Overactive Bladder

NCT03106623 ·Status: COMPLETED ·Phase: PHASE2

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666 ·Status: COMPLETED ·Phase: PHASE3

Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

NCT00821184 ·Status: TERMINATED ·Phase: PHASE3

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

NCT00857896 ·Status: COMPLETED ·Phase: PHASE2

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

NCT01488578 ·Status: COMPLETED

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

NCT00189800 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

NCT00840645 ·Status: COMPLETED ·Phase: PHASE3

Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

NCT02294396 ·Status: COMPLETED ·Phase: PHASE4

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

NCT04914221 ·Status: COMPLETED ·Phase: PHASE1

Study of ONO-8539 in Patients With Overactive Bladder

NCT00876421 ·Status: COMPLETED ·Phase: PHASE2

Post Marketing Surveillance Study on Emselex After Launch in Germany

NCT00786448 ·Status: COMPLETED

Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.

NCT02614482 ·Status: COMPLETED ·Phase: PHASE3

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

NCT03602508 ·Status: COMPLETED

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

NCT00985387 ·Status: COMPLETED

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

NCT02570035 ·Status: COMPLETED

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

NCT01500382 ·Status: TERMINATED ·Phase: PHASE1